MAC-Awake for Sevoflurane
MAC-awake for sevoflurane is approximately 0.3-0.35 MAC (or 0.6-0.7% end-tidal concentration in adults), representing the concentration at which 50% of patients respond to verbal commands during emergence from anesthesia.
Key Values and Clinical Context
The MAC-awake value represents the alveolar concentration at which patients transition between consciousness and unconsciousness. For sevoflurane:
- Standard adult MAC-awake: 0.6-0.7% end-tidal concentration 1
- Expressed as fraction of MAC: 0.3-0.35 MAC 1
- Age-dependent reduction: Decreases significantly with advancing age 2
Monitoring Requirements
Age-adjusted MAC must be monitored during use of inhaled anesthetic drugs 3. This is a guideline-level recommendation for all general anesthesia cases using volatile agents.
Important Clinical Considerations
Age-Related Adjustments
MAC-awake decreases with age, similar to the reduction in full MAC values 2. In elderly patients (80 years), the required concentration is approximately 50% of that needed in 20-year-olds 4.
Disease State Modifications
- Parkinson's disease: MAC-awake is significantly reduced to 0.47% (versus 0.64% in normal patients), representing a 27% reduction in anesthetic requirement 5
- Sleep disorders: MAC-awake is paradoxically increased to 0.80% (versus 0.60% in normal sleepers), requiring higher concentrations for emergence 6
Premedication Effects
Clonidine premedication (4.5 μg/kg oral) dramatically reduces MAC-awake from 0.66% to 0.35%, demonstrating potent hypnotic synergy 7.
Methodological Nuances
Fast vs. Slow Washout
A critical distinction exists between measurement techniques 1:
- Slow washout method (stepwise reduction allowing equilibration): MAC-awake = 0.34 MAC
- Fast washout method (abrupt discontinuation): Appears lower at 0.22 MAC due to brain-alveolar gradient
- Actual brain concentration at awakening: Remains constant at ~0.34 MAC regardless of measurement method
This explains why end-tidal concentrations during rapid emergence underestimate the true cerebral anesthetic concentration required for consciousness.
Safety Considerations
Respiratory Depression Risk
Sevoflurane causes dose-dependent respiratory depression 4. Monitor respiration closely during emergence, particularly when MAC-awake concentrations are maintained intentionally for procedures requiring spontaneous ventilation with sedation.
Hemodynamic Effects
Sevoflurane produces dose-dependent decreases in blood pressure 4. The insolubility of sevoflurane means hemodynamic changes occur more rapidly than with other volatile agents, requiring vigilant monitoring during concentration adjustments.
Pediatric Populations
In pediatric patients, MAC-awake values are approximately 25% higher than adults when combined with 50% nitrous oxide 4. Exercise particular caution as seizures have been reported, predominantly in children and young adults starting from 2 months of age 4.
Practical Application
To achieve MAC-awake intentionally (e.g., for awake fiberoptic intubation or emergence):
- Target end-tidal sevoflurane of 0.6-0.7% in healthy adults
- Reduce by ~50% in elderly patients (>80 years)
- Allow 15 minutes for brain-alveolar equilibration before testing response
- Adjust for premedications (particularly alpha-2 agonists)
- Consider patient-specific factors (Parkinson's disease, sleep disorders)
The log-normal distribution of awakening times among homogeneous patient populations 8 means individual variation exists even at identical MAC-awake concentrations, requiring individualized assessment of consciousness level.